Propanc Biopharma, Inc. (PPCB)
0.471
-0.03
(-5.55%)
USD |
NASDAQ |
Oct 08, 16:00
0.4635
-0.01
(-1.59%)
After-Hours: 20:00
Propanc Biopharma EPS Diluted (Quarterly) : -1.381 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.381 |
| March 31, 2026 | -7.09 |
| December 31, 2025 | -7.529 |
| September 30, 2025 | -9.808 |
| June 30, 2025 | -8.766 |
| March 31, 2025 | -312.46 |
| December 31, 2024 | -824.84 |
| September 30, 2024 | -0.0006 |
| June 30, 2024 | -0.0007 |
| March 31, 2024 | -0.0091 |
| December 31, 2023 | -0.026 |
| September 30, 2023 | -0.0449 |
| June 30, 2023 | -0.1336 |
| March 31, 2023 | -0.42 |
| December 31, 2022 | -0.53 |
| September 30, 2022 | -2.13 |
| June 30, 2022 | -5.26 |
| March 31, 2022 | -10.55 |
| December 31, 2021 | -18.09 |
| September 30, 2021 | -22.31 |
| June 30, 2021 | -83.30 |
| March 31, 2021 | -120.98 |
| December 31, 2020 | -448.18 |
| September 30, 2020 | -710.00 |
| June 30, 2020 | 4660.00 |
| Date | Value |
|---|---|
| March 31, 2020 | -348780.0 |
| December 31, 2019 | -1.251M |
| September 30, 2019 | -1.415M |
| June 30, 2019 | -1.654M |
| March 31, 2019 | -895000.0 |
| December 31, 2018 | -41.33M |
| September 30, 2018 | -9.445M |
| June 30, 2018 | -15.32M |
| March 31, 2018 | -30.00M |
| December 31, 2017 | -100.00M |
| September 30, 2017 | -180.00M |
| June 30, 2017 | -178.39M |
| March 31, 2017 | -0.019 |
| December 31, 2016 | -0.0565 |
| September 30, 2016 | -0.018 |
| June 30, 2016 | -0.049 |
| March 31, 2016 | -0.0526 |
| December 31, 2015 | -0.125 |
| September 30, 2015 | -0.03 |
| June 30, 2015 | -0.0657 |
| March 31, 2015 | -0.0281 |
| December 31, 2014 | -0.0455 |
| September 30, 2014 | -0.125 |
| June 30, 2014 | -0.0374 |
| March 31, 2014 | -0.0115 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -4.573M |
| Total Expenses (Quarterly) | 4.573M |
| Enterprise Value | 1.236M |
| Earnings Yield | -5.48K% |
| Normalized Earnings Yield | -5674.59 |